XOMAP Q2 2019 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena

XOMAPXOMA Corporation

$311M

Q2 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$962,000-57.3% YoY

Gross Profit

$238,00024.7% margin

Operating Income

-$5M-489.7% margin

Net Income

-$4M-423.3% margin

EPS (Diluted)

$-0.36

QoQ Revenue Growth

-88.2%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$9M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$78M

Total Liabilities

$57M

Stockholders' Equity

$21M

Cash & Equivalents

$42M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$962,000	$2M	-57.3%
Gross Profit	$238,000	$2M	-87.3%
Operating Income	-$5M	-$3M	-57.5%
Net Income	-$4M	-$2M	-109.1%